Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pathophysiology of NASH]

Yoshiyuki Takei1, Kenichi Ikejima, Nobuhiro Sato

  • 1Department of Gastroenterology, Juntendo University School of Medicine.

Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|December 2, 2004
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glycine attenuates double-stranded RNA-induced autoimmune cholangitis and pancreatitis by modulating innate immune signaling in mice.

The Journal of pharmacology and experimental therapeutics·2026
Same author

Association of serum albumin redox state with dietary protein intake and frailty in older adults: A cross-sectional study.

Clinical nutrition ESPEN·2026
Same author

Evidence-Based Clinical Practice Guidelines for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 2026.

Hepatology research : the official journal of the Japan Society of Hepatology·2026
Same author

Evidence-based clinical practice guidelines for metabolic dysfunction-associated steatotic liver disease (MASLD) 2026.

Journal of gastroenterology·2026
Same author

Perceived Impact of a Junior-Senior Inpatient Team Model on Clinical Workflow, Supervision, and Workload in a Tertiary Gastroenterology Department: A Mixed-Methods Study.

Journal of clinical medicine·2026
Same author

A case of complete remission with durvalumab-cabozantinib sequential therapy for advanced hepatocellular carcinoma.

Clinical journal of gastroenterology·2026